Therapeutic Molecules From Moss with eleva's Andreas Schaaf and Björn Cochlovius, Ph.D.
Business Of Biotech
00:00
The Legitimacy of Your Preclinical Pipeline
The February and Pompeii candidates are both clinical stage, you've got another line of projects in the pipeline that are preclinical. In general, however, looking at our at our technology, you can use it for any disease area. There's no doesn't matter whether it's oncology or or anything else that's that's no there's no limitation for that. But we would be looking into nephrology otherwise no limitation.
Transcript
Play full episode
